Tuesday, May 13, 2025

Yearly Archives: 2020

Monte Rosa Therapeutics Announces $96 Million to develop Protein Degradation molecule

September 24, 2020: "Monte Rosa Therapeutics, a biotechnology company focused on developing precision medicines to degrade disease-causing proteins, announced the closing of a Series...

FDA Approves First Drug to Treat Group of Rare Blood Disorders in Nearly 14 Years

September 25, 2020: "The U.S. Food and Drug Administration approved Nucala (mepolizumab) for adults and children aged 12 years and older with hypereosinophilic syndrome...

Coronavirus (COVID-19) Update: Daily Roundup September 25, 2020

September 25, 2020: "The U.S. Food and Drug Administration (FDA) continued to take action in the ongoing response to the COVID-19 pandemic: The FDA issued...

NHS COVID-19 app launches across England and Wales

September 24, 2020: "An NHS COVID-19 contact-tracing app has launched in England and Wales for people over the age of 16. The app, which was...

Coronavirus (COVID-19) Update: Daily Roundup September 24, 2020

September 24, 2020: "The U.S. Food and Drug Administration announced the following actions taken in its ongoing response effort to the COVID-19 pandemic: The FDA...

Verona Pharma Initiates late-stage COPD trial programme Initiates

 Sept. 23, 2020: "Verona Pharma, a clinical-stage biopharmaceutical company focused on respiratory diseases, announces the initiation of its ENHANCE (“Ensifentrine as a Novel inHAled...

Owlstone Medical’s Breath Biopsy test Improves Detection of Liver Disease

September 22 2020: "Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine announced the results of a patient study that...

FDA Authorizes First Point-of-Care Antibody Test for COVID-19

September 23, 2020: "The U.S.FDA issued an emergency use authorization (EUA) for the first serology (antibody) point-of-care (POC) test for COVID-19. The Assure COVID-19...

BMS Opdivo shows benefit in Gastric and Esophageal Cancers

September 21, 2020: "Bristol Myers Squibb announced primary results from CheckMate -649, the pivotal Phase 3 trial in which first-line treatment with Opdivo (nivolumab) plus chemotherapy showed a...

Sanofi and GSK sign agreements with Canada to supply up to 72 million doses of COVID-19 vaccine

September 22, 2020: "Sanofi and GSK have signed agreements with the Government of Canada for the supply of up to 72 million doses of...

Novartis Provides Update on AVXS-101 Intrathecal Clinical Development Program

September 23, 2020: "Novartis Gene Therapies recently received feedback from the US Food and Drug Administration (FDA) following their review of data from the STRONG...

Sanofi’s Supemtek® approved for the prevention of influenza in adults

September 22, 2020: "The European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) has adopted a positive opinion for Supemtek® (recombinant influenza...
- Advertisment -

Most Read